References for YK142 Mouse GLP-2 EIA Kit


1.
Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability.
Cani PD, Possemiers S, Van de Wiele T, Guiot Y, Everard A, Rottier O, Geurts L, Naslain D, Neyrinck A, Lambert DM, Muccioli GG, Delzenne NM.
Gut. 2009 Aug;58(8):1091-103. Epub 2009 Feb 24.

(Full)
2.
Regulation of MouseIntestinalLCellProgenitorsProliferation by the GlucagonFamily of Peptides.
Grigoryan M, Kedees MH, Charron MJ, Guz Y, Teitelman G.
Endocrinology. 2012 May 8. [Epub ahead of print]

(Abs)
3. Dipeptidyl peptidase-4 inhibitor anagliptin facilitates restoration of dextran sulfate sodium-induced colitis.
S. Mimura et .al., Scandinavian Journal of Gastroenterology October 2013, Vol. 48, No. 10 , Pages 1152-1159
(Abs)
4. Tumor Necrosis Factor  Decreases Glucagon-Like Peptide-2 Expression by Up-Regulating G-Protein-Coupled Receptor 120 in Crohn Disease.
Tsukahara T, Watanabe K, Watanabe T, Yamagami H, Sogawa M, Tanigawa T, Shiba M, Tominaga K, Fujiwara Y, Maeda K, Hirakawa K, Arakawa T.
Am J Pathol. 2015 Jan;185(1):185-96. doi: 10.1016/j.ajpath.2014.09.010. Epub 2014 Nov 5.(Abs)
5.  The combination of Bifidobacterium breve and Three Prebiotic Oligosaccharides Modifies Gut Immune and Endocrine Functions in Neonatal Mice.
Izumi H Ehara T Sugahara H Matsubara T Mitsuyama E  Nakazato Y Tsuda M , Shimizu T Odamaki TXiao JZ Takeda Y.                                                              
J Nutr, 2019 Feb 1;149(2):344-353.doi: 10.1093/jn/nxy248.